Residency · Residency · Otolaryngology

Acute Otitis Media: Evidence-Based Management

Overview

Acute otitis media (AOM) is one of the most common reasons for pediatric healthcare visits and antibiotic prescriptions. Evidence-based management requires distinguishing AOM from otitis media with effusion (OME) and applying observation criteria appropriately.

Epidemiology

The peak incidence of AOM occurs between 6 and 18 months of age, and by age three, approximately 80% of children will have experienced at least one episode. Risk factors include daycare attendance, bottle feeding in the supine position, pacifier use, sibling history of otitis media, male sex, craniofacial anomalies (such as cleft palate and Down syndrome), secondhand smoke exposure, and lack of breastfeeding. There is a notable seasonal variation, with higher incidence during winter months correlating with viral upper respiratory infection season.

Pathophysiology

Eustachian Tube Dysfunction

The pediatric eustachian tube is shorter, more horizontal, and more compliant than its adult counterpart, predisposing children to middle ear disease. When a viral upper respiratory infection causes mucosal edema and impairs mucociliary clearance, negative middle ear pressure develops. This negative pressure leads to aspiration of nasopharyngeal bacteria into the middle ear space, where bacterial proliferation in the trapped effusion produces acute infection.

Microbiology

Streptococcus pneumoniae was historically the most common pathogen, though its incidence has decreased since the introduction of the PCV13 vaccine. Non-typeable Haemophilus influenzae is now the most common causative organism and is frequently beta-lactamase producing. Moraxella catarrhalis is virtually 100% beta-lactamase producing but tends to cause milder disease. Group A Streptococcus is less common but carries an association with acute mastoiditis. Viral co-infection is present in the majority of AOM cases, with RSV, rhinovirus, influenza, and adenovirus being the most frequently identified agents.

Diagnosis

AAP/AAFP Diagnostic Criteria (2013 Guidelines)

Diagnosis of AOM requires one of the following: moderate to severe bulging of the tympanic membrane; new onset otorrhea not due to otitis externa; or mild bulging of the TM accompanied by either recent onset of ear pain (less than 48 hours) or intense erythema of the TM.

Key Examination Findings

Pneumatic otoscopy is the single most important diagnostic tool, with decreased or absent TM mobility being the hallmark finding. The classic appearance includes a bulging, opacified, and erythematous TM. Air-fluid levels or bubbles are more consistent with OME rather than AOM. Importantly, isolated erythema of the TM without effusion does not constitute AOM, as crying alone can cause TM erythema.

Distinguishing AOM from OME

Management

Observation Option (Watchful Waiting)

Observation without initial antibiotics is appropriate under specific criteria. For children aged 6 to 23 months, observation may be considered for unilateral AOM without severe symptoms (defined as mild otalgia lasting less than 48 hours and temperature below 39 degrees Celsius). For children aged 24 months and older, observation is appropriate for either unilateral or bilateral AOM without severe symptoms. In all cases, reliable follow-up within 48 to 72 hours must be ensured, and a safety-net antibiotic prescription ("SNAP") may be provided for use if symptoms worsen.

Antibiotic Therapy

First-Line

High-dose amoxicillin at 80-90 mg/kg/day divided twice daily is the first-line antibiotic for all children under 6 months, those with severe symptoms (moderate-to-severe otalgia, otalgia lasting more than 48 hours, or temperature at or above 39 degrees Celsius), those with bilateral AOM between ages 6 and 23 months, and children with recurrent AOM. The recommended duration is 10 days for children under 2 years, and 5 to 7 days for children 2 years and older with mild disease.

Second-Line (Treatment Failure at 48-72 hours or recent antibiotics)

Amoxicillin-clavulanate at 90 mg/kg/day (amoxicillin component) is the appropriate second-line choice, providing coverage against beta-lactamase producing organisms. Ceftriaxone given intramuscularly at 50 mg/kg for 3 days is an alternative for patients unable to tolerate oral medications.

Penicillin Allergy

For patients with a non-severe penicillin allergy, cefdinir, cefuroxime, or cefpodoxime are appropriate alternatives. For patients with a severe allergy (history of anaphylaxis), azithromycin or clindamycin may be used, though both provide poor coverage against H. influenzae.

Persistent Failure

When AOM persists despite second-line therapy, tympanocentesis for culture should be performed to guide targeted therapy. A combination of clindamycin plus a third-generation cephalosporin may be considered, and clinicians should consider the possibility of a concurrent viral process or resistant organism.

Pain Management

Analgesics are essential regardless of the antibiotic decision and should be considered a priority. Acetaminophen or ibuprofen at appropriate weight-based doses are first-line analgesics. Topical benzocaine-antipyrine otic drops may be used if the TM is intact. External heat application can provide additional comfort.

Complications

Intratemporal

Acute mastoiditis presents with persistent symptoms accompanied by postauricular swelling, erythema, tenderness, and forward displacement of the pinna. Petrositis (Gradenigo syndrome) manifests as the classic triad of retro-orbital pain, otorrhea, and sixth cranial nerve palsy. Facial nerve paralysis may occur but usually resolves with appropriate antibiotic treatment. Labyrinthitis produces vertigo and sensorineural hearing loss.

Intracranial

Meningitis is the most common intracranial complication of AOM. Other intracranial complications include epidural abscess, brain abscess (typically involving the temporal lobe or cerebellum), lateral sinus (sigmoid sinus) thrombosis characterized by a "picket fence" spiking fever pattern, and subdural empyema.

Recurrent AOM

Definition

Recurrent AOM is defined as 3 or more episodes in 6 months, or 4 or more episodes in 12 months with at least one occurring in the preceding 6 months.

Management Options

Management begins with addressing modifiable risk factors such as daycare exposure, passive smoke, and pacifier use. Ensuring that pneumococcal and influenza vaccinations are up to date is important. Tympanostomy tube placement is the most effective intervention for recurrent AOM, reducing episode frequency by approximately 50%. Prophylactic antibiotics are no longer recommended due to concerns about resistance and minimal demonstrated benefit.

Indications for Myringotomy and Tympanostomy Tubes

The primary indications include recurrent AOM as defined above, AOM with complications requiring culture via tympanocentesis, AOM unresponsive to multiple courses of antibiotics, and OME persisting for 3 months or longer with associated hearing loss.

<image>Otoscopic view comparing a normal tympanic membrane (translucent, neutral position, visible cone of light and malleus) with acute otitis media (bulging, opacified, erythematous tympanic membrane with loss of landmarks) and otitis media with effusion (retracted, amber-colored TM with visible air-fluid level). Three-panel comparison with labels.</image>

<image>Diagram of the pediatric eustachian tube compared to the adult eustachian tube, showing the shorter length, more horizontal orientation, and less developed cartilaginous support in children. Includes labeled sagittal cross-section of the nasopharynx with the eustachian tube orifice, tensor veli palatini, and levator veli palatini muscles.</image>

<image>Clinical algorithm flowchart for the management of acute otitis media based on the 2013 AAP guidelines. Decision nodes include age stratification (under 6 months, 6-23 months, 24 months and older), severity of symptoms, unilateral vs bilateral disease, and pathways to immediate antibiotics vs observation with safety-net prescription.</image>

Clinical Pearls

Pneumatic otoscopy is the single most important diagnostic tool -- an immobile, bulging TM is the hallmark of AOM. Erythema alone without effusion is NOT AOM, as crying and fever can cause TM erythema. High-dose amoxicillin (80-90 mg/kg/day) is first-line because it overcomes intermediate pneumococcal resistance. Pain management should never be overlooked -- analgesics are the priority regardless of the antibiotic decision. Observation is appropriate for most children over 2 years with non-severe, unilateral AOM. Amoxicillin-clavulanate (not a switch to a different antibiotic class) is the correct second-line choice for treatment failure. Acute mastoiditis presents with postauricular erythema, tenderness, and forward/lateral displacement of the pinna -- this requires urgent CT and often surgical drainage.

References

• Lieberthal AS, Carroll AE, Chonmaitree T, et al. "The diagnosis and management of acute otitis media." Pediatrics. 2013;131(3):e964-e999. (AAP Clinical Practice Guideline)
• Rosenfeld RM, Shin JJ, Schwartz SR, et al. "Clinical Practice Guideline: Otitis Media with Effusion (Update)." Otolaryngol Head Neck Surg. 2016;154(1 Suppl):S1-S41.
• Schilder AG, Chonmaitree T, Cripps AW, et al. "Otitis media." Nat Rev Dis Primers. 2016;2:16063.
• Vergison A, Dagan R, Arguedas A, et al. "Otitis media and its consequences: beyond the earache." Lancet Infect Dis. 2010;10(3):195-203.

Read this lecture as Markdown